Dimopoulos, Meletios A <br/><br/>
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group.  [electronic resource] 

 -  Gynecologic oncology  Jun 2002 
 - 476-82 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1006/gyno.2002.6649  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--administration & dosage<br/>Disease Progression<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Infusions, Intravenous<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local--drug therapy<br/>Outpatients<br/>Paclitaxel--administration & dosage<br/>Prospective Studies<br/>Survival Rate<br/>Uterine Cervical Neoplasms--drug therapy